SCHEMBL7877960

SCHEMBL7877960

CCOC(=O)c1cc2c(C(F)(F)F)cc(OCCCN(C)C)cc2n1C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.45
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
THRA P10827 3/20 0.41
THRB P10828 3/20 0.41
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
MAOA P21397 1/20 0.37
KDM4E B2RXH2 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PGR P06401 2/20 0.35
AR P10275 2/20 0.35
CYP1A2 P05177 1/20 0.35
ALOX5 P09917 1/20 0.34
NEK2 P51955 1/20 0.34
PLK1 P53350 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6799072 0.87 GAA (0.41) HPGDPOLBGAAALDH1A1KMT2A
SCHEMBL6799070 0.87 POLB (0.41) HPGDPOLBGAAALDH1A1MAOA
SCHEMBL6795763 0.85 POLB (0.38) HPGDPOLBGAAALDH1A1MAOA
SCHEMBL6797980 0.84 POLB (0.38) HPGDPOLBGAAALDH1A1MAOA
SCHEMBL6796884 0.83 AGER (0.40) HPGDPOLBGAAALDH1A1KMT2A
SCHEMBL7873290 0.81 DYRK1A (0.43) POLBGAAKDM4E
SCHEMBL7881981 0.80 SRD5A2 (0.45) HPGDGAAALDH1A1KMT2AMEN1
SCHEMBL6798270 0.80 PSEN1 (0.43) POLBGAAALDH1A1KMT2AMEN1
SCHEMBL6797332 0.80 POLB (0.34) HPGDPOLBGAAALDH1A1MAOA
SCHEMBL6798564 0.79 LDHA (0.36) HPGDPOLBGAAALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1051301-C Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 2000-04-12 CN disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
CN-1106800-A Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 1995-08-16 CN disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed